Validity of 1% Hormonal Receptor Positivity Cutoff by the ASCO/College of American Pathologists Guidelines at the Georgia Cancer Center

Kreidieh, F; Sadek, RF; Zhang, L; Gopal, A; Blaize, JP; Yashar, D; Patel, R; Patel, HS; Tang, SC; Sater, HA

Sater, HA (通讯作者),Cleveland Clin, Carol & Robert Weissman Canc Ctr, 501 SE Osceola St Suite 301, Stuart, FL 34994 USA.

JCO PRECISION ONCOLOGY, 2022; 6 ():

Abstract

PURPOSE Treatment of breast cancer (BC) with borderline or low (1%-9%) estrogen and progesterone expression remains controversial, with recent data di......

Full Text Link